SG153894G - Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient - Google Patents

Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Info

Publication number
SG153894G
SG153894G SG153894A SG153894A SG153894G SG 153894 G SG153894 G SG 153894G SG 153894 A SG153894 A SG 153894A SG 153894 A SG153894 A SG 153894A SG 153894 G SG153894 G SG 153894G
Authority
SG
Singapore
Prior art keywords
embonate
azelastin
active ingredient
pharmaceutical compositions
preparation
Prior art date
Application number
SG153894A
Other languages
English (en)
Inventor
Gerhard Dr Scheffler
Dieter Sauerbier
Juergen Dr Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP88117969A priority Critical patent/EP0316639B1/fr
Priority to ES88117969T priority patent/ES2053679T3/es
Priority to AT88117969T priority patent/ATE106883T1/de
Priority to DE3850044T priority patent/DE3850044D1/de
Priority to DE3836749A priority patent/DE3836749A1/de
Priority to CA000582812A priority patent/CA1317595C/fr
Priority to DK630088A priority patent/DK170339B1/da
Priority to JP63285946A priority patent/JP2730581B2/ja
Priority to US07/598,742 priority patent/US5232919A/en
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Priority to SG153894A priority patent/SG153894G/en
Priority to HK135494A priority patent/HK135494A/xx
Publication of SG153894G publication Critical patent/SG153894G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG153894A 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient SG153894G (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES88117969T ES2053679T3 (es) 1987-11-13 1988-10-28 Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
AT88117969T ATE106883T1 (de) 1987-11-13 1988-10-28 Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
DE3850044T DE3850044D1 (de) 1987-11-13 1988-10-28 Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
DE3836749A DE3836749A1 (de) 1987-11-13 1988-10-28 Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten
EP88117969A EP0316639B1 (fr) 1987-11-13 1988-10-28 Azélastine-embonate, procédé pour sa préparation et préparations pharmaceutiques qui contiennent l'azélastine-embonate comme produit actif
CA000582812A CA1317595C (fr) 1987-11-13 1988-11-10 Embonate d'azelastine, procedes pour sa preparation et formulations pharmaceutiques en contenant comme substance active
DK630088A DK170339B1 (da) 1987-11-13 1988-11-11 Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler
JP63285946A JP2730581B2 (ja) 1987-11-13 1988-11-14 アゼラスチン・エンボネート、その製法、該化合物を含有する経口投与用調剤、安定な水性懸濁液及びエーロゾル、これらの製法及び経口投与用懸濁液並びに固体調剤の製法
US07/598,742 US5232919A (en) 1987-11-13 1990-10-15 Azelastine embonate and compositions which contain it
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
HK135494A HK135494A (en) 1987-11-13 1994-12-01 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Publications (1)

Publication Number Publication Date
SG153894G true SG153894G (en) 1995-03-17

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Country Status (9)

Country Link
EP (1) EP0316639B1 (fr)
JP (1) JP2730581B2 (fr)
AT (1) ATE106883T1 (fr)
CA (1) CA1317595C (fr)
DE (1) DE3850044D1 (fr)
DK (1) DK170339B1 (fr)
ES (1) ES2053679T3 (fr)
HK (1) HK135494A (fr)
SG (1) SG153894G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013696A1 (de) * 1989-05-05 1990-11-08 Asta Pharma Ag Salze des azelastins mit verbesserter loeslichkeit
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
DK2486942T3 (en) 2004-11-24 2019-01-28 Meda Pharmaceuticals Inc COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (fr) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
JPH01153686A (ja) 1989-06-15
DE3850044D1 (de) 1994-07-14
EP0316639A3 (en) 1990-07-18
HK135494A (en) 1994-12-09
DK630088A (da) 1989-05-14
DK170339B1 (da) 1995-08-07
EP0316639A2 (fr) 1989-05-24
ATE106883T1 (de) 1994-06-15
DK630088D0 (da) 1988-11-11
CA1317595C (fr) 1993-05-11
JP2730581B2 (ja) 1998-03-25
ES2053679T3 (es) 1994-08-01
EP0316639B1 (fr) 1994-06-08

Similar Documents

Publication Publication Date Title
TW229208B (fr)
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
AU3575984A (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE59001121D1 (en) Antacidatabletten.
AU8452891A (en) Calcium uptake inhibitors
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
HUT41002A (en) Process for preparing anticonvulsives
TW218011B (fr)
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
IE883402L (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
JO1531B1 (en) New near-compounds
JO1843B1 (en) Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione
JO1711B1 (en) Therapeutic agents